Remove 2022 Remove Homecare Remove Hospice Remove Personal care
article thumbnail

Addus HomeCare Expects 2024 Acquisitions

Hospice News

Addus HomeCare Corp. NASDAQ: ADUS) is poised for further acquisitions, potentially including some hospice deals. The company is seeking to pair its clinical services with its personal business in its existing markets. Hospice revenue per day was up 3.7% Hospice revenue per day was up 3.7% The company saw 11.6%

Homecare 194
article thumbnail

Addus HomeCare to Accelerate Acquisition Activity

Hospice News

Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. Its hospice segment earned $53.1 million, up 12.6%

Homecare 218
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

Addus Orients M&A Strategy Away From Hospice, Towards Home Health, Personal Care

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.

article thumbnail

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. In Q1 2023, Addus’ hospice segment brought in $49.08

article thumbnail

Hospice Investors to Watch in 2024

Hospice News

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. This followed its $5.4 NYSE: HUM) for $2.8

2024 245
article thumbnail

Addus Projects ‘Strong, Steady’ Hospice Growth Amid Lingering Pandemic Census Headwinds

Hospice News

Addus HomeCare Corp. NASDAQ: ADUS) saw hospice growth in 2023, despite lingering pandemic-related challenges around daily census. The company anticipates growth in its personal care business in 2024, which will have a reverberating impact in its hospice and home health service lines. million.

2024 147